A Study of LY3526318 in Healthy Participants

NCT03977974 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

76

Enrollment

INDUSTRY

Sponsor class

Stopped COVID-19 pandemic.

Conditions

Healthy

Interventions

DRUG: LY3526318
DRUG: Placebo

Sponsor

Eli Lilly and Company